Cite
HARVARD Citation
Lackner, M. et al. (2018). Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei. Journal of antimicrobial chemotherapy. pp. 3068-3073. [Online].